BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

DepoCyte® 50 mg injectable suspension (liposomal cytarabine for intrathecal injection): Back on the market as of 1 August 2013

Active substance: liposomal cytarabine

As of 1 August 2013, DepoCyte® will be available again regularly on the German market.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 175KB, File is accessible